Diabetes
Conference Coverage
Vitality predicts T2DM major cardiovascular event risk
“Not feeling full of pep and not having a lot of energy could be used as risk markers for MACE in patients with type 2 diabetes.”
From the Journals
Oral semaglutide achieves outcomes similar to those of subcutaneous semaglutide
In an oral versus subcutaneous smackdown, either semaglutide preparation is effective.
Conference Coverage
Exercise reduces T1DM mortality risk
LISBON - Exercise was associated with a lower risk of all-cause mortality in patients with type 1 diabetes mellitus, regardless of whether or not...
Conference Coverage
Nearly 10% of patients with candidemia had CDI
SAN DIEGO – Patients with diabetes, hemodialysis, solid organ transplantation, or a prior recent hospital stay are at increased risk of...
From the Journals
Intensive exercise didn’t improve glycemic control for obese pregnant women
How can the adverse outcomes associated with obesity and hyperglycemia during pregnancy be prevented?
Conference Coverage
Triple therapy for type 2 diabetes goes beyond glucose control
LISBON – All you need to improve poorly controlled diabetes may be a bigger hammer.
Conference Coverage
Intensified approach reduces long-term heart failure risk in T2DM
T2DM sharply ups heart failure risk, but intensified multifactorial treatment reduces the risk.
From the Journals
Insulin pumps associated with lower risk of ketoacidosis and severe hypoglycemia in kids
Keep risk low by pumping up insulin.
Conference Coverage
Semaglutide aids T2DM weight loss over 2 years
GI side effects do not explain sustained weight loss with semaglutide in patients with type 2 diabetes.
Conference Coverage
Fasting glucose fluctuations, severe hypoglycemia up T2DM death risk
Evenly maintained blood glucose levels may save lives in T2DM.
Latest News
Many years on metformin linked to anemia risk
LISBON – Why cumulative metformin use is associated with an increased risk of anemia is unclear, and needs to be investigated further, according...